March 28–31, 2026 – Yokohama, Japan
World Congress of Nephrology (WCN) 2026
The World Congress of Nephrology (WCN) is a yearly global event dedicated to kidney health.
Travere Therapeutics was excited to participate in the event and engage with nephrology leaders from around the world.
Implications of Proteinuria Remission on Estimated Glomerular Filtration Rate Trajectory in Patients With IgA Nephropathy in PROTECT
Speakers: Hiddo JL. Heerspink, Vladimir Tesar, Radko Komers, Bruce M. Hendry, Priscila Preciado, Edward Murphy, Brad H. Rovin on behalf of the DUPRO Steering Committee and PROTECT investigators
Contact Your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Contact an MSLSparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial
Speakers: Chee Kay Cheung, Stephanie Moody, Neeraj Dhaun, Siàn Griffin, Alexandra Howson, Radko Komers, Alex Mercer, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt
MA-DS-24-0068 | January 2026